Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form
Br J Dermatol
.
2022 Oct;187(4):588-589.
doi: 10.1111/bjd.21593.
Epub 2022 May 31.
Authors
Christine Blome
1
,
Catharina C von Stülpnagel
1
,
Matthias Augustin
1
,
Ulrich Mrowietz
2
,
Kristian Reich
1
,
Holger Muehlan
3
,
Natalia Kirsten
1
,
Anna K Langenbruch
1
,
Christina Sorbe
1
,
Toni M Klein
1
Affiliations
1
Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
2
Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany.
3
Department Health & Prevention, Institute of Psychology, University of Greifswald, Germany.
PMID:
35383904
DOI:
10.1111/bjd.21593
No abstract available
Publication types
Letter
MeSH terms
Humans
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Psychometrics